Spyre Therapeutics Share Price (NASDAQ: SYRE)
$16.1
Last updated on
Check the interactive Spyre Therapeutics Stock chart to analyse performance
Spyre Therapeutics stock performance
as on August 20, 2025 at 1:29 AM IST
- Today's Low:$15.91Today's High:$16.52
1.18%
Downside
Day's Volatility :3.69%
Upside
2.54%
- 52 Weeks Low:$10.9152 Weeks High:$40.26
32.24%
Downside
52 Weeks Volatility :72.9%
Upside
60.01%
Spyre Therapeutics Stock Returns
Spyre Therapeutics Inc Key Stats
Check Spyre Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Spyre Therapeutics Stock including INR - Dollar returns
The Spyre Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Spyre Therapeutics investment value today
Current value as on today
₹61,434
Returns
Returns from Spyre Therapeutics Stock
Dollar Returns*
₹3,624 (+3.62%)
Indian investors sentiment towards Spyre Therapeutics Stock
Analyst Recommendation on Spyre Therapeutics Stock
Buy
92%Buy
7%Hold
0%Sell
Based on 13 Wall street analysts offering stock ratings for Spyre Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Spyre Therapeutics Share Price Target
What analysts predicted
Upside of 240.92%
Target:
$54.89
Current:
$16.10
Spyre Therapeutics share price target is $54.89, a slight Upside of 240.92% compared to current price of $16.10 as per analysts' prediction.
Spyre Therapeutics Stock Insights
Price Movement
In the last 7 days, SYRE stock has moved up by 6.7%Increasing Revenue
Revenue is up for the last 4 quarters, 168.0K → 1.04M (in $), with an average increase of 40.1% per quarterIncreasing Net Profit
Netprofit is up for the last 4 quarters, -69.02M → -36.71M (in $), with an average increase of 23.4% per quarterSYRE vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.4% return, outperforming this stock by 105.5%SYRE vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 137.0%
Spyre Therapeutics Technicals Summary
Sell
Neutral
Buy
Spyre Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Spyre Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 3.73% | -24.18% | -36.46% | -10.01% | -89.58% |
 | 5.3% | -16.22% | -51.82% | -6.15% | -5.13% |
| 9.32% | 34.83% | 64.32% | 84.48% | 32.68% |
 | -14.97% | -17.36% | -20.01% | 32.68% | 43.71% |
 | 42.53% | 82.36% | 62.72% | 109.65% | 234.44% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 1.72 | NA | NA | -2.75 | -0.5 | -0.28 | NA | 4.97 |
| 14.62 | 14.62 | 1.19 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.33 | -0.05 | -0.01 | NA | 34.32 |
| 27.94 | 27.94 | 0.58 | 18.04 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $1.0B | -89.58% | 1.72 | 0.0% |
| Buy | $61.5B | -5.13% | 14.62 | 31.37% |
| NA | $38.8B | 32.68% | NA | -3.89% |
| Buy | $100.7B | 43.71% | 27.94 | 31.86% |
| Buy | $58.8B | 234.44% | NA | -12.96% |
About Spyre Therapeutics Inc
Key Management of Spyre Therapeutics Inc
Important FAQs about investing in SYRE Stock from India :
What is Spyre Therapeutics share price today?
Spyre Therapeutics share price today is $16.10 as on at the close of the market. Spyre Therapeutics share today touched a day high of $16.52 and a low of $15.91.
What is the 52 week high and 52 week low for Spyre Therapeutics share?
Spyre Therapeutics share touched a 52 week high of $40.26 and a 52 week low of $10.91. Spyre Therapeutics stock price today i.e. is closed at $16.10, lower by 60.01% versus the 52 week high.
How to invest in Spyre Therapeutics Stock (SYRE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Spyre Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Spyre Therapeutics Shares that will get you 0.0932 shares as per Spyre Therapeutics share price of $16.10 per share as on August 20, 2025 at 1:29 AM IST.
What is the minimum amount required to buy Spyre Therapeutics Stock (SYRE) from India?
Indian investors can start investing in Spyre Therapeutics (SYRE) shares with as little as ₹86.938 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹869.38 in Spyre Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 20, 2025).
Based on Spyre Therapeutics share’s latest price of $16.10 as on August 20, 2025 at 1:29 AM IST, you will get 0.6211 shares of Spyre Therapeutics. Learn more about
fractional shares .
What are the returns that Spyre Therapeutics has given to Indian investors in the last 5 years?
Spyre Therapeutics stock has given -89.58% share price returns and 16.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
Discover More
- Carlsmed Inc
$12.61
-4.32%
- Fundvantage Tr Polen Flt Rate
$24.63
+0.16%
Bondbloxx Usd Hy Bond Cons Cyclicals Sctr Etf$37.18
+0.41%
- Zega Buy And Hedge Etf
$21.79
-0.95%
- Invesco Bs 2033 Hycb Etf
$25.44
+0.12%
Lifezone Metals Ltd$4.34
-3.56%
- Real Asset Acquisition Corp.
$10.36
+0.29%
- Primech Holdings Ltd
$1.56
+0.65%
Abeona Therapeutics Inc.$6.84
-1.01%